Elanix Biotechnologies AG | Key People and Executives
Jürgen Ferdinand Kullmann
Chairman-Supervisory Board
Marc Voigt
Vice Chairman-Supervisory Board
Abigael de Buys Roessingh
Member-Supervisory Board
Jürgen Ferdinand Kullmann
Chairman-Supervisory Board
Tomas J. Svoboda
Chief Executive Officer
Egon Minar
Chief Operating & Financial Officer
Corinne Scaletta
Co-Founder
Nathalie Hirt-Burri
Co-Founder
Anthony De Buys Roessingh
Co-Founder
Wassim Raffoul
Co-Founder
Marc Voigt
Vice Chairman-Supervisory Board
Abigael de Buys Roessingh
Member-Supervisory Board
Magdalena Onyszkiewicz
Manager-Marketing & Public Relations
Bruno Tenaille
Head-Sales & Marketing
Maria Widowski
Investor Relations Contact
Riccardo Nisato
Head-Regulatory Affairs & Quality Assurance
| Address |
Hohenstaufenstrasse 1
Wiesbaden Hessen 65189
Germany
|
|
Employees
|
- |
| Website |
http://www.elanix-biotechnologies.de |
| Updated |
07/08/2019 |
| Elanix Biotechnologies AG operates as a holding company, which engages in the development and marketing of progenitor cell-based products for acute wound care, as well as dermatological and gynecological applications. It operates through the Regenerative Medicine and Cosmetic Ointments business segments. The Regenerative Medicine segment offers skin dressings made from progenitor skin fibroblasts to provide protection and accelerated healing for burns and reconstructive surgery. |
